首页> 美国卫生研究院文献>Thorax >Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD
【2h】

Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD

机译:慢性阻塞性肺病中类固醇治疗后肺功能变化与抑制活性氮产生的相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

>Background: Reactive nitrogen species (RNS) have a number of inflammatory actions and the production of these molecules has been reported to be increased in the airways of patients with chronic obstructive pulmonary disease (COPD), which suggests that they may be involved in the inflammatory and obstructive process in COPD. >Methods: The relationship between the reduction in RNS and the improvement in pulmonary function was studied in 18 patients with COPD following steroid treatment (800 µg beclomethasone dipropionate inhalation for 4 weeks). Twelve patients were treated with inhaled steroids and the others received placebo treatment. Forced expiratory volume in 1 second (FEV1) and airway responsiveness to histamine were measured before and after treatment. Induced sputum cells were stained with anti-nitrotyrosine antibody, a footprint of RNS, and RNS formation was assessed by measuring nitrotyrosine immunoreactivity. The immunoreactivity of inducible nitric oxide synthase (iNOS) in induced sputum and exhaled NO levels were also measured. >Results: Treatment with steroids resulted in a significant reduction in both nitrotyrosine and iNOS immunoreactivity in sputum cells compared with pretreatment levels (both p<0.01). The reduction rates in both parameters were significantly related (p<0.05). The reduction in nitrotyrosine and iNOS immunoreactivity was correlated with the improvement in FEV1 (p<0.05) and airway responsiveness to histamine (p<0.01). None of the parameters was significantly changed by placebo administration. >Conclusions: These results suggest that RNS may be involved in the reversible component of inflammation in COPD that is suppressed by steroids. Further studies using specific inhibitors for RNS are needed to clarify their effects on the long term progression of COPD.
机译:>背景:活性氮物质(RNS)具有多种炎症作用,据报道这些分子在慢性阻塞性肺疾病(COPD)患者气道中的产生增加。它们可能参与了COPD的炎症和阻塞过程。 >方法:研究了18例接受类固醇治疗的COPD患者RNS降低与肺功能改善之间的关系(吸入800 µg丙酸倍氯米松4周)。 12位患者接受了吸入类固醇的治疗,其他患者接受了安慰剂治疗。在治疗之前和之后,测量1秒钟的强制呼气量(FEV1)和气道对组胺的反应性。诱导的痰细胞用抗硝基酪氨酸抗体染色,RNS足迹,并通过测量硝基酪氨酸免疫反应性来评估RNS的形成。还测量了诱导性一氧化氮合酶(iNOS)在诱导痰中的免疫反应性和呼出的NO水平。 >结果:与治疗前相比,类固醇治疗可使痰细胞中的硝酸酪氨酸和iNOS免疫反应性显着降低(均p <0.01)。两个参数的降低率均显着相关(p <0.05)。硝基酪氨酸和iNOS免疫反应性的降低与FEV1的改善(p <0.05)和气道对组胺的反应性(p <0.01)相关。服用安慰剂后,所有参数均无明显变化。 >结论:这些结果表明RNS可能参与了类固醇抑制的COPD炎症的可逆成分。需要进一步研究使用RNS的特异性抑制剂来阐明其对COPD长期进展的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号